318 related articles for article (PubMed ID: 11500805)
1. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
Box NF; Duffy DL; Chen W; Stark M; Martin NG; Sturm RA; Hayward NK
Am J Hum Genet; 2001 Oct; 69(4):765-73. PubMed ID: 11500805
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.
Bastiaens MT; ter Huurne JA; Kielich C; Gruis NA; Westendorp RG; Vermeer BJ; Bavinck JN;
Am J Hum Genet; 2001 Apr; 68(4):884-94. PubMed ID: 11254446
[TBL] [Abstract][Full Text] [Related]
3. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.
van der Velden PA; Sandkuijl LA; Bergman W; Pavel S; van Mourik L; Frants RR; Gruis NA
Am J Hum Genet; 2001 Oct; 69(4):774-9. PubMed ID: 11500806
[TBL] [Abstract][Full Text] [Related]
4. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma.
Box NF; Duffy DL; Irving RE; Russell A; Chen W; Griffyths LR; Parsons PG; Green AC; Sturm RA
J Invest Dermatol; 2001 Feb; 116(2):224-9. PubMed ID: 11179997
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
Kennedy C; ter Huurne J; Berkhout M; Gruis N; Bastiaens M; Bergman W; Willemze R; Bavinck JN
J Invest Dermatol; 2001 Aug; 117(2):294-300. PubMed ID: 11511307
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?
Palmer JS; Duffy DL; Box NF; Aitken JF; O'Gorman LE; Green AC; Hayward NK; Martin NG; Sturm RA
Am J Hum Genet; 2000 Jan; 66(1):176-86. PubMed ID: 10631149
[TBL] [Abstract][Full Text] [Related]
8. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
9. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.
Koulermou G; Shammas C; Vassiliou A; Kyriakides TC; Costi C; Neocleous V; Phylactou LA; Pantelidou M
J Genet; 2017 Mar; 96(1):155-160. PubMed ID: 28360400
[TBL] [Abstract][Full Text] [Related]
11. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
[TBL] [Abstract][Full Text] [Related]
13. Skin colour and skin cancer - MC1R, the genetic link.
Sturm RA
Melanoma Res; 2002 Oct; 12(5):405-16. PubMed ID: 12394181
[TBL] [Abstract][Full Text] [Related]
14. Genetics of melanoma predisposition.
Hayward NK
Oncogene; 2003 May; 22(20):3053-62. PubMed ID: 12789280
[TBL] [Abstract][Full Text] [Related]
15. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation.
Scott MC; Wakamatsu K; Ito S; Kadekaro AL; Kobayashi N; Groden J; Kavanagh R; Takakuwa T; Virador V; Hearing VJ; Abdel-Malek ZA
J Cell Sci; 2002 Jun; 115(Pt 11):2349-55. PubMed ID: 12006619
[TBL] [Abstract][Full Text] [Related]
16. Genetic association and cellular function of MC1R variant alleles in human pigmentation.
Sturm RA; Duffy DL; Box NF; Newton RA; Shepherd AG; Chen W; Marks LH; Leonard JH; Martin NG
Ann N Y Acad Sci; 2003 Jun; 994():348-58. PubMed ID: 12851335
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
18. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
[TBL] [Abstract][Full Text] [Related]
20. Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
Puig-Butille JA; Escámez MJ; Garcia-Garcia F; Tell-Marti G; Fabra À; Martínez-Santamaría L; Badenas C; Aguilera P; Pevida M; Dopazo J; del Río M; Puig S
Oncotarget; 2014 Mar; 5(6):1439-51. PubMed ID: 24742402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
